CoChat

New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food

Open access
Ambroselli, Donatella, Masciulli, Fabrizio, Romano, Enrico, Catanzaro, Giuseppina, Besharat, Zein Mersini, Massari, Maria Chiara, Ferretti, Elisabetta, Migliaccio, Silvia, Izzo, Luana, Ritieni, Alberto, Grosso, Michela, Formichi, Caterina, Dotta, Francesco, Frigerio, Francesco, Barbiera, Eleonora, Giusti, Anna Maria, Ingallina, Cinzia, Mannina, Luisa · 2023 · Nutrients
Cited by 214

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

The definition of metabolic syndrome (MetS) has undergone several changes over the years due to the difficulty in establishing universal criteria for it. Underlying the disorders related to MetS is almost invariably a pro-inflammatory state related to altered glucose metabolism, which could lead to elevated cardiovascular risk. Indeed, the complications closely related to MetS are cardiovascular diseases (CVDs) and type 2 diabetes (T2D). It has been observed that the predisposition to metabolic syndrome is modulated by complex interactions between human microbiota, genetic factors, and diet. This review provides a summary of the last decade of literature related to three principal aspects of MetS: (i) the syndrome’s definition and classification, pathophysiology, and treatment approaches; (ii) prediction and diagnosis underlying the biomarkers identified by means of advanced methodologies (NMR, LC/GC-MS, and LC, LC-MS); and (iii) the role of foods and food components in prevention and/or treatment of MetS, demonstrating a possible role of specific foods intake in the development of MetS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu15030640

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 190

  1. Levesque, 2008, The Metabolic Syndrome: Definitions, Prevalence and Management, J. Nutr. Nutr., 1, 100
  2. Sarafidis, 2006, The Metabolic Syndrome: A Glance at Its History, J. Hypertens., 24, 621, 10.1097/01.hjh.0000217840.26971.b6 · DOI · Paper page
  3. DeFronzo, 1991, Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease, Diabetes Care, 14, 173, 10.2337/diacare.14.3.173 · DOI · Paper page
  4. Kaplan, 1989, The Deadly Quartet. Upper-Body Obesity, Glucose Intolerance, Hypertriglyceridemia, and Hypertension, Arch. Intern. Med., 149, 1514, 10.1001/archinte.1989.00390070054005 · DOI · Paper page
  5. Pasternak, 2003, Report of the Adult Treatment Panel III: The 2001 National Cholesterol Education Program Guidelines on the Detection, Evaluation and Treatment of Elevated Cholesterol in Adults, Cardiol. Clin., 21, 393, 10.1016/S0733-8651(03)00080-8 · doi:10.1016/s0733-8651(03)00080-8
  6. Alberti, 1998, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Provisional Report of a WHO Consultation, Diabet. Med., 15, 539, 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S · doi:10.1002/(sici)1096-9136(199807)15:7<539::aid-dia668>3.0.co;2-s
  7. Alberti, 2009, Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; And International Association for the Study of Obesity, Circulation, 120, 1640, 10.1161/CIRCULATIONAHA.109.192644 · DOI · Paper page
  8. Bovolini, 2021, Metabolic Syndrome Pathophysiology and Predisposing Factors, Int. J. Sports Med., 42, 199, 10.1055/a-1263-0898 · DOI · Paper page
  9. Debnath, 2016, Metaflammatory Responses during Obesity: Pathomechanism and Treatment, Obes. Res. Clin. Pract., 10, 103, 10.1016/j.orcp.2015.10.012 · DOI
  10. Rochlani, 2017, Metabolic Syndrome: Pathophysiology, Management, and Modulation by Natural Compounds, Ther. Adv. Cardiovasc. Dis., 11, 215, 10.1177/1753944717711379 · DOI · Paper page
  11. Boden, 2002, Free Fatty Acids in Obesity and Type 2 Diabetes: Defining Their Role in the Development of Insulin Resistance and β-Cell Dysfunction, Eur. J. Clin. Invest., 32, 14, 10.1046/j.1365-2362.32.s3.3.x · DOI · Paper page
  12. McCracken, 2018, Pathophysiology of the Metabolic Syndrome, Clin. Dermatol., 36, 14, 10.1016/j.clindermatol.2017.09.004 · DOI · Paper page
  13. Li, 2021, Impact of Metabolic Syndrome and It’s Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis, Front. Cardiovasc. Med., 8, 704145, 10.3389/fcvm.2021.704145 · DOI
  14. American Diabetes Association (2021). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care, 44, S15–S33. · DOI · Paper page
  15. Gaines, 2018, Obstructive Sleep Apnea and the Metabolic Syndrome: The Road to Clinically-Meaningful Phenotyping, Improved Prognosis, and Personalized Treatment, Sleep Med. Rev., 42, 211, 10.1016/j.smrv.2018.08.009 · DOI · Paper page
  16. Wluka, A., Cicuttini, F.M., and Spector, T.D. (1998). Obesity, Arthritis, and Gout, CRC Press.
  17. Vainio, 2002, Weight Control and Physical Activity in Cancer Prevention: International Evaluation of the Evidence, Eur. J. Cancer Prev., 11, S94
  18. Uzunlulu, 2016, Association between Metabolic Syndrome and Cancer, Ann. Nutr. Metab., 68, 179, 10.1159/000443743 · DOI · Paper page
  19. Pujia, 2022, Advances in Phenotyping Obesity and in Its Dietary and Pharmacological Treatment: A Narrative Review, Front. Nutr., 9, 804719, 10.3389/fnut.2022.804719 · DOI
  20. Frank, 2019, Determinants of body fat distribution in humans may provide insight about obesity-related health risks, J. Lipid Res., 60, 1710, 10.1194/jlr.R086975 · DOI · Paper page
  21. Nguyen, 2008, Association of Hypertension, Diabetes, Dyslipidemia, and Metabolic Syndrome with Obesity: Findings from the National Health and Nutrition Examination Survey, 1999 to 2004, J. Am. Coll. Surg., 207, 928, 10.1016/j.jamcollsurg.2008.08.022 · DOI · Paper page
  22. Skurk, 2004, Obesity and Impaired Fibrinolysis: Role of Adipose Production of Plasminogen Activator Inhibitor-1, Int. J. Obes., 28, 1357, 10.1038/sj.ijo.0802778 · DOI · Paper page
  23. Atar, 2021, New Cardiovascular Prevention Guidelines: How to Optimally Manage Dyslipidaemia and Cardiovascular Risk in 2021 in Patients Needing Secondary Prevention?, Atherosclerosis, 319, 51, 10.1016/j.atherosclerosis.2020.12.013 · DOI
  24. Friedman, 2018, Mechanisms of NAFLD Development and Therapeutic Strategies, Nat. Med., 24, 908, 10.1038/s41591-018-0104-9 · DOI · Paper page
  25. Salvio, G., Ciarloni, A., Cutini, M., Delli Muti, N., Finocchi, F., Perrone, M., Rossi, S., and Balercia, G. (2022). Metabolic Syndrome and Male Fertility: Beyond Heart Consequences of a Complex Cardiometabolic Endocrinopathy. Int. J. Mol. Sci., 23. · DOI
  26. Gatto, 2008, Metabolic Syndrome and Cognitive Function in Healthy Middle-Aged and Older Adults without Diabetes, Aging Neuropsychol. Cogn., 15, 627, 10.1080/13825580802036936 · DOI · Paper page
  27. Taylor, 2007, Cognitive Dysfunction Associated with Metabolic Syndrome, Obes. Rev., 8, 409, 10.1111/j.1467-789X.2007.00401.x · DOI · Paper page
  28. 2012, Impaired Glucose Tolerance and Metabolic Syndrome in Idiopathic Neuropathy, J. Peripher. Nerv. Syst., 17, 15, 10.1111/j.1529-8027.2012.00390.x · DOI
  29. Pal, 2018, Mild Cognitive Impairment and Progression to Dementia in People with Diabetes, Prediabetes and Metabolic Syndrome: A Systematic Review and Meta-Analysis, Soc. Psychiatry Psychiatr. Epidemiol., 53, 1149, 10.1007/s00127-018-1581-3 · DOI · Paper page
  30. Nishikawa, H., Asai, A., Fukunishi, S., Nishiguchi, S., and Higuchi, K. (2021). Metabolic Syndrome and Sarcopenia. Nutrients, 13. · DOI · Paper page
  31. Zuin, M., Rigatelli, G., Bilato, C., Cervellati, C., Zuliani, G., and Roncon, L. (2021). Prognostic Role of Metabolic Syndrome in COVID-19 Patients: A Systematic Review Meta-Analysis. Viruses, 13. · DOI
  32. Pugliese, 2022, Obesity and Infectious Diseases: Pathophysiology and Epidemiology of a Double Pandemic Condition, Int. J. Obes., 46, 449, 10.1038/s41366-021-01035-6 · DOI · Paper page
  33. Costa, 2020, Metabolic Syndrome and COVID-19: An Update on the Associated Comorbidities and Proposed Therapies, Diabetes Metab. Syndr. Clin. Res. Rev., 14, 809, 10.1016/j.dsx.2020.06.016 · DOI · Paper page
  34. Sobolev, A.P., Ciampa, A., Ingallina, C., Mannina, L., Capitani, D., Ernesti, I., Maggi, E., Businaro, R., del Ben, M., and Engel, P. (2019). Blueberry-Based Meals for Obese Patients with Metabolic Syndrome: A Multidisciplinary Metabolomic Pilot Study. Metabolites, 9. · DOI
  35. Pasanta, 2019, Effects of Obesity on the Lipid and Metabolite Profiles of Young Adults by Serum 1H-NMR Spectroscopy, PeerJ, 7, e7137, 10.7717/peerj.7137 · DOI
  36. Salek, 2007, A Metabolomic Comparison of Urinary Changes in Type 2 Diabetes in Mouse, Rat, and Human, Physiol. Genom., 29, 99, 10.1152/physiolgenomics.00194.2006 · DOI · Paper page
  37. Kim, 2009, 1H-Nuclear Magnetic Resonance Spectroscopy-Based Metabolic Assessment in a Rat Model of Obesity Induced by a High-Fat Diet, Anal. Bioanal Chem, 395, 1117, 10.1007/s00216-009-3054-8 · DOI
  38. Zhang, 2021, NMR Spectroscopy Based Metabolomics Confirms the Aggravation of Metabolic Disorder in Metabolic Syndrome Combined with Hyperuricemia, Nutr. Metab. Cardiovasc. Dis., 31, 2449, 10.1016/j.numecd.2021.05.015 · DOI
  39. Burkart, 2016, What Have Metabolomics Approaches Taught Us About Type 2 Diabetes?, Curr. Diab. Rep., 16, 74, 10.1007/s11892-016-0763-1 · DOI
  40. Mediani, 2017, Metabolite Variation in Lean and Obese Streptozotocin (STZ)-Induced Diabetic Rats via 1H NMR-Based Metabolomics Approach, Appl. Biochem. Biotechnol., 182, 653, 10.1007/s12010-016-2352-9 · DOI
  41. Gruppen, 2018, A Novel NMR-Based Assay to Measure Circulating Concentrations of Branched-Chain Amino Acids: Elevation in Subjects with Type 2 Diabetes Mellitus and Association with Carotid Intima Media Thickness, Clin. Biochem., 54, 92, 10.1016/j.clinbiochem.2018.02.001 · DOI
  42. Tillin, 2015, Diabetes Risk and Amino Acid Profiles: Cross-Sectional and Prospective Analyses of Ethnicity, Amino Acids and Diabetes in a South Asian and European Cohort from the SABRE (Southall And Brent REvisited) Study, Diabetologia, 58, 968, 10.1007/s00125-015-3517-8 · DOI · Paper page
  43. Tiainen, 2012, Circulating Metabolite Predictors of Glycemia in Middle-Aged Men and Women, Diabetes Care, 35, 1749, 10.2337/dc11-1838 · DOI · Paper page
  44. Shaari, 2019, Urine NMR Metabolomic Study on Biochemical Activities to Investigate the Effect of P. Betle Extract on Obese Rats, Appl. Biochem. Biotechnol., 189, 690, 10.1007/s12010-019-03042-w · DOI
  45. Won, E.Y., Yoon, M.K., Kim, S.W., Jung, Y., Bae, H.W., Lee, D., Park, S.G., Lee, C.H., Hwang, G.S., and Chi, S.W. (2013). Gender-Specific Metabolomic Profiling of Obesity in Leptin-Deficient Ob/Ob Mice by 1H NMR Spectroscopy. PLoS ONE, 8. · DOI
  46. Cheng, 2014, Serum Metabolic Profiles in Overweight and Obese Women with and without Metabolic Syndrome, Diabetol. Metab. Syndr., 6, 40, 10.1186/1758-5996-6-40 · DOI
  47. Surowiec, 2019, Metabolomic and Lipidomic Assessment of the Metabolic Syndrome in Dutch Middle-Aged Individuals Reveals Novel Biological Signatures Separating Health and Disease, Metabolomics, 15, 23, 10.1007/s11306-019-1484-7 · DOI
  48. Dai, 2015, Exploring Metabolic Syndrome Serum Free Fatty Acid Profiles Based on GC-SIM-MS Combined with Random Forests and Canonical Correlation Analysis, Talanta, 135, 108, 10.1016/j.talanta.2014.12.039 · DOI
  49. Yun, H., Sun, L., Wu, Q., Zong, G., Qi, Q., Li, H., Zheng, H., Zeng, R., Liang, L., and Lin, X. (2020). Associations among Circulating Sphingolipids, β-Cell Function, and Risk of Developing Type 2 Diabetes: A Population-Based Cohort Study in China. PLoS Med., 17. · DOI
  50. Yun, H., Qi, Q.B., Zong, G., Wu, Q.Q., Niu, Z.H., Chen, S.S., Li, H.X., Sun, L., Zeng, R., and Lin, X. (2021). Plasma Sphingolipid Profile in Association with Incident Metabolic Syndrome in a Chinese Population-Based Cohort Study. Nutrients, 13. · DOI
  51. Lin, 2014, Exploring Metabolic Syndrome Serum Profiling Based on Gas Chromatography Mass Spectrometry and Random Forest Models, Anal. Chim. Acta, 827, 22, 10.1016/j.aca.2014.04.008 · DOI
  52. Esperanza, 2020, Liquid Chromatography-Mass Spectrometry Untargeted Metabolomics Reveals Increased Levels of Tryptophan Indole Metabolites in Urine of Metabolic Syndrome Patients, Eur. J. Mass Spectrom., 26, 379, 10.1177/1469066720964632 · DOI
  53. Bruzzone, 2021, A Molecular Signature for the Metabolic Syndrome by Urine Metabolomics, Cardiovasc. Diabetol., 20, 155, 10.1186/s12933-021-01349-9 · DOI
  54. Bombelli, 2018, Uric Acid and Risk of New-Onset Metabolic Syndrome, Impaired Fasting Glucose and Diabetes Mellitus in a General Italian Population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni Study, J. Hypertens., 36, 1492, 10.1097/HJH.0000000000001721 · DOI
  55. Saito, 2017, Establishment of an Analytical Method for Accurate Purity Evaluations of Acylcarnitines by Using Quantitative 1H NMR Spectroscopy, Accredit. Qual. Assur., 22, 171, 10.1007/s00769-017-1263-y · doi:10.1007/s00769-017-1263-y
  56. Lawler, 2016, Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality Risk, Circ. Res., 118, 1106, 10.1161/CIRCRESAHA.115.308078 · DOI
  57. Otvos, 2015, GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation, Clin. Chem., 61, 714, 10.1373/clinchem.2014.232918 · DOI · Paper page
  58. Ritchie, 2015, The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection, Cell Syst., 1, 293, 10.1016/j.cels.2015.09.007 · DOI · Paper page
  59. Adosraku, 1994, NMR Lipid Profiles of Cells, Tissues, and Body Fluids: Proton NMR Analysis of Human Erythrocyte Lipids, J. Lipid Res., 35, 1925, 10.1016/S0022-2275(20)39939-9 · doi:10.1016/s0022-2275(20)39939-9
  60. Guo, 2016, Quantitative Metabolomic Profiling of Plasma, Urine, and Liver Extracts by 1H NMR Spectroscopy Characterizes Different Stages of Atherosclerosis in Hamsters, J. Proteome Res., 15, 3500, 10.1021/acs.jproteome.6b00179 · DOI
  61. Hart, 2018, Blood Metabolomic Measures Associate with Present and Future Glycemic Control in Type 2 Diabetes, J. Clin. Endocrinol. Metab., 103, 4569, 10.1210/jc.2018-01165 · DOI
  62. Denimal, 2016, Major Changes in the Sphingophospholipidome of HDL in Non-Diabetic Patients with Metabolic Syndrome, Atherosclerosis, 246, 106, 10.1016/j.atherosclerosis.2015.12.042 · DOI
  63. Mikhailidis, 2017, Lifestyle Recommendations for the Prevention and Management of Metabolic Syndrome: An International Panel Recommendation, Nutr. Rev., 75, 307, 10.1093/nutrit/nux014 · DOI · Paper page
  64. Bahadori, 2019, Recent Advances in Nanotechnology for the Treatment of Metabolic Syndrome, Diabetes Metab. Syndr. Clin. Res. Rev., 13, 1561, 10.1016/j.dsx.2019.03.002 · DOI
  65. Xie, 2021, The Effects and Mechanisms of Exercise on the Treatment of Depression, Front. Psychiatry, 12, 705559, 10.3389/fpsyt.2021.705559 · DOI · Paper page
  66. Kapoor, 2022, Physical Activity for Health and Fitness: Past, Present and Future, J. Lifestyle Med., 12, 9, 10.15280/jlm.2022.12.1.9 · DOI
  67. Myers, J., Kokkinos, P., and Nyelin, E. (2019). Physical Activity, Cardiorespiratory Fitness, and the Metabolic Syndrome. Nutrients, 11. · DOI · Paper page
  68. Reljic, 2020, Low-Volume High-Intensity Interval Training Improves Cardiometabolic Health, Work Ability and Well-Being in Severely Obese Individuals: A Randomized-Controlled Trial Sub-Study, J. Transl. Med., 18, 419, 10.1186/s12967-020-02592-6 · DOI · Paper page
  69. Chiang, 2019, Active Physical Activity Patterns Are Associated with Improved Quality of Life and Depression Status in Taiwanese Women with Metabolic Syndrome, J. Cardiovasc. Nurs., 34, 491, 10.1097/JCN.0000000000000602 · DOI
  70. Haufe, 2020, Employers With Metabolic Syndrome and Increased Depression/Anxiety Severity Profit Most From Structured Exercise Intervention for Work Ability and Quality of Life, Front. Psychiatry, 11, 562, 10.3389/fpsyt.2020.00562 · DOI
  71. Emerenziani, 2018, Effects of an Individualized Home-Based Unsupervised Aerobic Training on Body Composition and Physiological Parameters in Obese Adults Are Independent of Gender, J. Endocrinol. Investig., 41, 465, 10.1007/s40618-017-0771-2 · DOI
  72. Emerenziani, 2019, Effects of Body Weight Loss Program on Parameters of Muscle Performance in Female Obese Adults, J. Sport. Med. Phys. Fit., 59, 624
  73. 2019, Applying Framingham Risk Score 2008 to Predict the 10-Year Risk of Cardiovascular Disease in a Group of Office Workers in Hanoi, Vietnam, VNU J. Sci. Med. Pharm. Sci., 35, 128
  74. Geidenstam, 2017, Metabolite Profiling of Obese Individuals before and after a One Year Weight Loss Program, Int. J. Obes., 41, 1369, 10.1038/ijo.2017.124 · DOI
  75. Geidenstam, N., Hsu, Y.H.H., Astley, C.M., Mercader, J.M., Ridderstråle, M., Gonzalez, M.E., Gonzalez, C., Hirschhorn, J.N., and Salem, R.M. (2019). Using Metabolite Profiling to Construct and Validate a Metabolite Risk Score for Predicting Future Weight Gain. PLoS ONE, 14. · DOI
  76. Pigsborg, 2022, Metabotyping for Precision Nutrition and Weight Management: Hype or Hope?, Curr. Nutr. Rep., 11, 117, 10.1007/s13668-021-00392-y · DOI
  77. Walsh, 2017, Metabotyping for the Development of Tailored Dietary Advice Solutions in a European Population: The Food4Me Study, Br. J. Nutr., 118, 561, 10.1017/S0007114517002069 · DOI
  78. Gijbels, 2021, The PERSonalized Glucose Optimization Through Nutritional Intervention (PERSON) Study: Rationale, Design and Preliminary Screening Results, Front. Nutr., 8, 694568, 10.3389/fnut.2021.694568 · DOI
  79. Wu, 2021, Multi-Stage Metabolomics and Genetic Analyses Identified Metabolite Biomarkers of Metabolic Syndrome and Their Genetic Determinants, EBioMedicine, 74, 103707, 10.1016/j.ebiom.2021.103707 · DOI
  80. Riedl, 2017, Metabotyping and Its Application in Targeted Nutrition: An Overview, Br. J. Nutr., 117, 1631, 10.1017/S0007114517001611 · DOI
  81. Agodi, A., Maugeri, A., Kunzova, S., Sochor, O., Bauerova, H., Kiacova, N., Barchitta, M., and Vinciguerra, M. (2018). Association of Dietary Patterns with Metabolic Syndrome: Results from the Kardiovize Brno 2030 Study. Nutrients, 10. · DOI · Paper page
  82. Lee, 2016, Protective Effects of the Mediterranean Diet on Type 2 Diabetes and Metabolic Syndrome, J. Nutr., 146, 920S, 10.3945/jn.115.218487 · DOI · Paper page
  83. Ramzan, F., Vickers, M.H., and Mithen, R.F. (2021). Epigenetics, Microrna and Metabolic Syndrome: A Comprehensive Review. Int. J. Mol. Sci., 22. · DOI
  84. Milagro, 2016, Expression of Inflammation-Related MiRNAs in White Blood Cells from Subjects with Metabolic Syndrome after 8 Wk of Following a Mediterranean Diet-Based Weight Loss Program, Nutrition, 32, 48, 10.1016/j.nut.2015.06.008 · DOI
  85. Gillies, 2012, Regulation of Inflammatory and Lipid Metabolism Genes by Eicosapentaenoic Acid-Rich Oil, J. Lipid Res., 53, 1679, 10.1194/jlr.M022657 · DOI
  86. Ide, 2005, Interaction of Fish Oil and Conjugated Linoleic Acid in Affecting Hepatic Activity of Lipogenic Enzymes and Gene Expression in Liver and Adipose Tissue, Diabetes, 54, 412, 10.2337/diabetes.54.2.412 · DOI · Paper page
  87. Ortega, 2015, Circulating Profiling Reveals the Effect of a Polyunsaturated Fatty Acid-Enriched Diet on Common MicroRNAs, J. Nutr. Biochem., 26, 1095, 10.1016/j.jnutbio.2015.05.001 · DOI
  88. Castro-Barquero, S., Ruiz-León, A.M., Sierra-Pérez, M., Estruch, R., and Casas, R. (2020). Dietary Strategies for Metabolic Syndrome: A Comprehensive Review. Nutrients, 12. · DOI · Paper page
  89. Wan, 2003, Intermittent Food Deprivation Improves Cardiovascular and Neuroendocrine Responses to Stress in Rats, J. Nutr., 133, 1921, 10.1093/jn/133.6.1921 · DOI · Paper page
  90. Kim, 2012, Comparison of the Chemical Compositions and Nutritive Values of Various Pumpkin (Cucurbitaceae) Species and Parts, Nutr. Res. Pract., 6, 21, 10.4162/nrp.2012.6.1.21 · doi:10.4162/nrp.2012.6.1.21 · Paper page
  91. Abdelkader, 2022, Pumpkin Seed Proteins (Cucurbita Pepo, L.) Protect against Diet-Induced Metabolic Syndrome by Improving Insulin Resistance and Markers of Oxidative Stress and Inflammation in Rats, Biologia, 77, 2677, 10.1007/s11756-022-01112-9 · DOI
  92. Akrami, 2020, A Comparative Study of the Effect of Flaxseed Oil and Sunflower Oil on the Coagulation Score, Selected Oxidative and Inflammatory Parameters in Metabolic Syndrome Patients, Clin. Nutr. Res., 9, 63, 10.7762/cnr.2020.9.1.63 · DOI
  93. Din, 2013, Effect of ω-3 Fatty Acid Supplementation on Endothelial Function, Endogenous Fibrinolysis and Platelet Activation in Male Cigarette Smokers, Heart, 99, 168, 10.1136/heartjnl-2012-302924 · DOI
  94. Sangouni, 2021, Effects of Garlic Powder Supplementation on Metabolic Syndrome Components, Insulin Resistance, Fatty Liver Index, and Appetite in Subjects with Metabolic Syndrome: A Randomized Clinical Trial, Phytother. Res., 35, 4433, 10.1002/ptr.7146 · DOI
  95. Rezazadeh, 2018, Antioxidant Response to Artichoke Leaf Extract Supplementation in Metabolic Syndrome: A Double-Blind Placebo-Controlled Randomized Clinical Trial, Clin. Nutr., 37, 790, 10.1016/j.clnu.2017.03.017 · DOI
  96. Li, 2014, Preventative Effect of Zingiber Officinale on Insulin Resistance in a High-Fat High-Carbohydrate Diet-Fed Rat Model and Its Mechanism of Action, Basic Clin. Pharmacol. Toxicol., 115, 209, 10.1111/bcpt.12196 · DOI · Paper page
  97. Mateos, 2018, Regularly Consuming a Green/Roasted Coffee Blend Reduces the Risk of Metabolic Syndrome, Eur. J. Nutr., 57, 269, 10.1007/s00394-016-1316-8 · DOI
  98. Wu, G., Sun, X., Cheng, H., Xu, S., Li, D., and Xie, Z. (2022). Large Yellow Tea Extract Ameliorates Metabolic Syndrome by Suppressing Lipogenesis through SIRT6/SREBP1 Pathway and Modulating Microbiota in Leptin Receptor Knockout Rats. Foods, 11. · DOI
  99. Lee, 2019, Fruit and Vegetable Consumption and the Metabolic Syndrome: A Systematic Review and Dose-Response Meta-Analysis, Br. J. Nutr., 122, 723, 10.1017/S000711451900165X · DOI
  100. Zhang, 2018, Associations of Vegetable and Fruit Consumption with Metabolic Syndrome. A Meta-Analysis of Observational Studies, Public Health Nutr., 21, 1693, 10.1017/S1368980018000381 · DOI · Paper page
  101. Tian, 2018, Fruit and Vegetable Consumption and Risk of the Metabolic Syndrome: A Meta-Analysis, Public Health Nutr., 21, 756, 10.1017/S136898001700310X · DOI · Paper page
  102. Pap, 2021, Berry Polyphenols and Human Health: Evidence of Antioxidant, Anti-Inflammatory, Microbiota Modulation, and Cell-Protecting Effects, Curr. Opin. Food Sci., 42, 167, 10.1016/j.cofs.2021.06.003 · DOI · Paper page
  103. Lozovoy, 2013, Reduced-Energy Cranberry Juice Increases Folic Acid and Adiponectin and Reduces Homocysteine and Oxidative Stress in Patients with the Metabolic Syndrome, Br. J. Nutr., 110, 1885, 10.1017/S0007114513001207 · DOI
  104. Aboonabi, 2020, Anthocyanins in Berries Exhibited Anti-Atherogenicity and Antiplatelet Activities in a Metabolic Syndrome Population, Nutr. Res., 76, 82, 10.1016/j.nutres.2020.02.011 · DOI
  105. Carresi, C., Gliozzi, M., Musolino, V., Scicchitano, M., Scarano, F., Bosco, F., Nucera, S., Maiuolo, J., Macrì, R., and Ruga, S. (2020). The Effect of Natural Antioxidants in the Development of Metabolic Syndrome: Focus on Bergamot Polyphenolic Fraction. Nutrients, 12. · DOI
  106. Salerno, 2016, Characterization of Flavonoids in Citrus Bergamia (Bergamot) Polyphenolic Fraction by Liquid Chromatography–High Resolution Mass Spectrometry (LC/HRMS), PharmaNutrition, 4, S1, 10.1016/j.phanu.2015.10.001 · DOI
  107. Arabi, 2022, Impact of Walnut Consumption on Cardio Metabolic and Anthropometric Parameters in Metabolic Syndrome Patients: GRADE-Assessed Systematic Review and Dose-Response Meta-Analysis of Data from Randomized Controlled Trials, Pharmacol. Res., 178, 106190, 10.1016/j.phrs.2022.106190 · DOI
  108. Hwang, 2019, Daily Walnut Intake Improves Metabolic Syndrome Status and Increases Circulating Adiponectin Levels: Randomized Controlled Crossover Trial, Nutr. Res. Pract., 13, 105, 10.4162/nrp.2019.13.2.105 · DOI
  109. Reverri, 2015, Black Beans, Fiber, and Antioxidant Capacity Pilot Study: Examination of Whole Foods vs. Functional Components on Postprandial Metabolic, Oxidative Stress, and Inflammation in Adults with Metabolic Syndrome, Nutrients, 7, 6139, 10.3390/nu7085273 · DOI
  110. Azadbakht, 2007, Soy Inclusion in the Diet Improves Features of the Metabolic Syndrome: A Randomized Crossover Study in Postmenopausal Women, Am. J. Clin. Nutr., 85, 735, 10.1093/ajcn/85.3.735 · DOI · Paper page
  111. Ruscica, 2018, Effect of Soy on Metabolic Syndrome and Cardiovascular Risk Factors: A Randomized Controlled Trial, Eur. J. Nutr., 57, 499, 10.1007/s00394-016-1333-7 · DOI
  112. Guo, 2021, Associations of Whole Grain and Refined Grain Consumption With Metabolic Syndrome. A Meta-Analysis of Observational Studies, Front. Nutr., 8, 695620, 10.3389/fnut.2021.695620 · DOI · Paper page
  113. Song, 2014, Carbohydrate Intake and Refined-Grain Consumption Are Associated with Metabolic Syndrome in the Korean Adult Population, J. Acad Nutr. Diet., 114, 54, 10.1016/j.jand.2013.08.025 · DOI
  114. Sahyoun, 2006, Whole-Grain Intake Is Inversely Associated with the Metabolic Syndrome and Mortality in Older Adults, Am. J. Clin. Nutr., 83, 124, 10.1093/ajcn/83.1.124 · DOI · Paper page
  115. Esmaillzadeh, 2005, Whole-Grain Consumption and the Metabolic Syndrome: A Favorable Association in Tehranian Adults, Eur. J. Clin. Nutr., 59, 353, 10.1038/sj.ejcn.1602080 · DOI · Paper page
  116. Liu, 2000, A Prospective Study of Whole-Grain Intake and Risk of Type 2 Diabetes Mellitus in US Women, Am. J. Public Health, 90, 1409, 10.2105/AJPH.90.9.1409 · DOI · Paper page
  117. Giacco, 2013, Effects of Rye and Whole Wheat versus Refined Cereal Foods on Metabolic Risk Factors: A Randomised Controlled Two-Centre Intervention Study, Clin. Nutr., 32, 941, 10.1016/j.clnu.2013.01.016 · DOI
  118. Giacco, 2014, A Whole-Grain Cereal-Based Diet Lowers Postprandial Plasma Insulin and Triglyceride Levels in Individuals with Metabolic Syndrome, Nutr. Metab. Cardiovasc. Dis., 24, 837, 10.1016/j.numecd.2014.01.007 · DOI
  119. Huang, L., Wang, H., Wang, Z., Zhang, J., Zhang, B., and Ding, G. (2019). Regional Disparities in the Association between Cereal Consumption and Metabolic Syndrome: Results from the China Health and Nutrition Survey. Nutrients, 11. · DOI
  120. Kang, 2020, Grain Subtype and the Combination of Grains Consumed Are Associated with the Risk of Metabolic Syndrome: Analysis of a Community-Based Prospective Cohort, J. Nutr., 150, 118, 10.1093/jn/nxz179 · DOI
  121. Zhou, 2022, DHPPA, a Major Plasma Alkylresorcinol Metabolite Reflecting Whole-Grain Wheat and Rye Intake, and Risk of Metabolic Syndrome: A Case-Control Study, Eur. J. Nutr., 61, 3247, 10.1007/s00394-022-02880-5 · DOI
  122. Yang, 2012, Rice Protein Improves Adiposity, Body Weight and Reduces Lipids Level in Rats through Modification of Triglyceride Metabolism, Lipids Health Dis., 11, 118, 10.1186/1476-511X-11-24 · DOI
  123. Bahrami, 2022, Adherence to the Mediterranean Diet and the Risk of Lung Cancer: A Systematic Review and Dose-Response Meta-Analysis of Observational Studies, Nutr. Rev., 80, 1118, 10.1093/nutrit/nuab117 · DOI
  124. Gorzynik-Debicka, M., Przychodzen, P., Cappello, F., Kuban-Jankowska, A., Gammazza, A.M., Knap, N., Wozniak, M., and Gorska-Ponikowska, M. (2018). Potential Health Benefits of Olive Oil and Plant Polyphenols. Int. J. Mol. Sci., 19. · DOI · Paper page
  125. Violi, 2015, Extra Virgin Olive Oil Use Is Associated with Improved Post-Prandial Blood Glucose and LDL Cholesterol in Healthy Subjects, Nutr. Diabetes, 5, e172, 10.1038/nutd.2015.23 · DOI · Paper page
  126. Venturini, 2015, Effects of Extra Virgin Olive Oil and Fish Oil on Lipid Profile and Oxidative Stress in Patients with Metabolic Syndrome, Nutrition, 31, 834, 10.1016/j.nut.2014.12.016 · DOI
  127. Raatz, 2013, Issues of Fish Consumption for Cardiovascular Disease Risk Reduction, Nutrients, 5, 1081, 10.3390/nu5041081 · DOI · Paper page
  128. Rylander, C., Sandanger, T.M., Engeset, D., and Lund, E. (2014). Consumption of Lean Fish Reduces the Risk of Type 2 Diabetes Mellitus: A Prospective Population Based Cohort Study of Norwegian Women. PLoS ONE, 9. · DOI
  129. Kim, 2015, Fish Consumption, Long-Chain Omega-3 Polyunsaturated Fatty Acid Intake and Risk of Metabolic Syndrome: A Meta-Analysis, Nutrients, 7, 2085, 10.3390/nu7042085 · DOI · Paper page
  130. Li, 2021, Effect of Low-Ratio n-6/n-3 PUFA on Blood Lipid Level: A Meta-Analysis, Hormones, 20, 697, 10.1007/s42000-020-00248-0 · DOI
  131. Jiang, 2022, “Big Data” Approaches for Prevention of the Metabolic Syndrome, Front. Genet., 13, 810152, 10.3389/fgene.2022.810152 · DOI
  132. Coltell, O., Sorlí, J.V., Asensio, E.M., Barragán, R., González, J.I., Giménez-Alba, I.M., Zanón-Moreno, V., Estruch, R., Ramírez-Sabio, J.B., and Pascual, E.C. (2020). Genome-Wide Association Study for Serum Omega-3 and Omega-6 Polyunsaturated Fatty Acids: Exploratory Analysis of the Sex-Specific Effects and Dietary Modulation in Mediterranean Subjects with Metabolic Syndrome. Nutrients, 12. · DOI
  133. Lai, 2013, Association of Dietary Omega-3 Fatty Acids with Prevalence of Metabolic Syndrome: The National Heart, Lung, and Blood Institute Family Heart Study, Clin. Nutr., 32, 966, 10.1016/j.clnu.2013.05.002 · DOI
  134. Denisenko, 2015, Metabolic Syndrome: Modification of the Fatty Acid Composition and Glucose-Insulin Homeostasis, Br. J. Med. Med. Res., 8, 975, 10.9734/BJMMR/2015/18536 · DOI
  135. Huang, 2010, Plasma Phospholipids N-3 Polyunsaturated Fatty Acid Is Associated with Metabolic Syndrome, Mol. Nutr. Food Res., 54, 1628, 10.1002/mnfr.201000025 · DOI · Paper page
  136. Dai, 2016, Association between N-3 Polyunsaturated Fatty Acids in Erythrocytes and Metabolic Syndrome in Chinese Men and Women, Eur. J. Nutr., 55, 981, 10.1007/s00394-015-0912-3 · DOI
  137. Chien, 2011, Plasma Fatty Acids and the Risk of Metabolic Syndrome in Ethnic Chinese Adults in Taiwan, Lipids Health Dis., 10, 33, 10.1186/1476-511X-10-33 · DOI
  138. Zaribaf, 2014, Fish Consumption Is Inversely Associated with the Metabolic Syndrome, Eur. J. Clin. Nutr., 68, 474, 10.1038/ejcn.2014.5 · DOI
  139. Mirmiran, 2019, The Association between Fish Consumption and Risk of Metabolic Syndrome in Adults: Tehran Lipid and Glucose Study, Int. J. Vitam. Nutr. Res., 89, 192, 10.1024/0300-9831/a000561 · DOI
  140. Mirmiran, 2012, Association between Interaction and Ratio of ω-3 and ω-6 Polyunsaturated Fatty Acid and the Metabolic Syndrome in Adults, Nutrition, 28, 856, 10.1016/j.nut.2011.11.031 · DOI
  141. Kim, 2016, Intake of Fish and Long-Chain Omega-3 Polyunsaturated Fatty Acids and Incidence of Metabolic Syndrome among American Young Adults: A 25-Year Follow-up Study, Eur. J. Nutr., 55, 1707, 10.1007/s00394-015-0989-8 · DOI
  142. Kim, 2018, Impact of Fish Consumption by Subjects with Prediabetes on the Metabolic Risk Factors: Using Data in the 2015 (6th) Korea National Health and Nutrition Examination Surveys, Nutr. Res. Pract., 12, 233, 10.4162/nrp.2018.12.3.233 · DOI
  143. Molin, 2016, Associations between Fish Consumption and Metabolic Syndrome. A Large Cross-Sectional Study from the Norwegian Tromsø Study: Tromsø 4, Diabetol. Metab. Syndr., 8, 18, 10.1186/s13098-016-0137-5 · DOI
  144. Tørris, C., Molin, M., and Småstuen, M.C. (2017). Lean Fish Consumption Is Associated with Beneficial Changes in the Metabolic Syndrome Components: A 13-Year Follow-up Study from the Norwegian Tromsø Study. Nutrients, 9. · DOI
  145. Poudyal, 2013, Effects of ALA, EPA and DHA in High-Carbohydrate, High-Fat Diet-Induced Metabolic Syndrome in Rats, J. Nutr. Biochem., 24, 1041, 10.1016/j.jnutbio.2012.07.014 · DOI · Paper page
  146. Tardivo, 2015, Effects of Omega-3 on Metabolic Markers in Postmenopausal Women with Metabolic Syndrome, Climacteric, 18, 290, 10.3109/13697137.2014.981521 · DOI
  147. Lee, 2014, The Impact of Polyunsaturated Fatty Acid-Based Dietary Supplements on Disease Biomarkers in a Metabolic Syndrome/Diabetes Population, Lipids Health Dis., 13, 196, 10.1186/1476-511X-13-196 · DOI
  148. Ortega, 2016, Dietary Supplementation with Omega-3 Fatty Acids and Oleate Enhances Exercise Training Effects in Patients with Metabolic Syndrome, Obesity, 24, 1704, 10.1002/oby.21552 · DOI · Paper page
  149. Corella, 2014, White Fish Reduces Cardiovascular Risk Factors in Patients with Metabolic Syndrome: The WISH-CARE Study, a Multicenter Randomized Clinical Trial, Nutr. Metab. Cardiovasc. Dis., 24, 328, 10.1016/j.numecd.2013.09.018 · DOI
  150. Pandey, 2009, Plant Polyphenols as Dietary Antioxidants in Human Health and Disease, Oxid. Med. Cell. Longev., 2, 270, 10.4161/oxim.2.5.9498 · DOI · Paper page
  151. Ghani, U. (2020). Alpha-Glucosidase Inhibitors, Elsevier. [1st ed.].
  152. Singla, 2019, Natural Polyphenols: Chemical Classification, Definition of Classes, Subcategories, and Structures, J. AOAC Int., 102, 1397, 10.5740/jaoacint.19-0133 · doi:10.5740/jaoacint.19-0133 · Paper page
  153. Amiot, 2016, Effects of Dietary Polyphenols on Metabolic Syndrome Features in Humans: A Systematic Review, Obes. Rev., 17, 573, 10.1111/obr.12409 · DOI · Paper page
  154. Parhiz, 2015, Antioxidant and Anti-Inflammatory Properties of the Citrus Flavonoids Hesperidin and Hesperetin: An Updated Review of Their Molecular Mechanisms and Experimental Models, Phytother. Res., 29, 323, 10.1002/ptr.5256 · DOI · Paper page
  155. Barth, 2012, Moderate Effects of Apple Juice Consumption on Obesity-Related Markers in Obese Men: Impact of Diet-Gene Interaction on Body Fat Content, Eur. J. Nutr., 51, 841, 10.1007/s00394-011-0264-6 · DOI
  156. Pons, 2015, Effects of Total Dietary Polyphenols on Plasma Nitric Oxide and Blood Pressure in a High Cardiovascular Risk Cohort. The PREDIMED Randomized Trial, Nutr. Metab. Cardiovasc. Dis., 25, 60, 10.1016/j.numecd.2014.09.001 · DOI · Paper page
  157. Macready, 2014, Flavonoid-Rich Fruit and Vegetables Improve Microvascular Reactivity and Inflammatory Status in Men at Risk of Cardiovascular Disease-FLAVURS: A Randomized Controlled Trial, Am. J. Clin. Nutr., 99, 479, 10.3945/ajcn.113.074237 · DOI · Paper page
  158. Qin, 2016, Apigenin and Naringenin Ameliorate PKCβII-Associated Endothelial Dysfunction via Regulating ROS/Caspase-3 and NO Pathway in Endothelial Cells Exposed to High Glucose, Vascul. Pharmacol., 85, 39, 10.1016/j.vph.2016.07.006 · DOI
  159. Duarte, 2013, Apigenin Protects Endothelial Cells from Lipopolysaccharide (LPS)-Induced Inflammation by Decreasing Caspase-3 Activation and Modulating Mitochondrial Function, Int. J. Mol. Sci., 14, 17664, 10.3390/ijms140917664 · DOI
  160. Wang, 2014, Flavonol Intake and Stroke Risk: A Meta-Analysis of Cohort Studies, Nutrition, 30, 518, 10.1016/j.nut.2013.10.009 · DOI
  161. McCullough, 2012, Flavonoid Intake and Cardiovascular Disease Mortality in a Prospective Cohort of US Adults, Am. J. Clin. Nutr., 95, 454, 10.3945/ajcn.111.016634 · DOI · Paper page
  162. Cassidy, 2016, Habitual Intake of Anthocyanins and Flavanones and Risk of Cardiovascular Disease in Men, Am. J. Clin. Nutr., 104, 587, 10.3945/ajcn.116.133132 · DOI · Paper page
  163. Dower, 2016, Dietary Epicatechin Intake and 25-y Risk of Cardiovascular Mortality: The Zutphen Elderly Study, Am. J. Clin. Nutr., 104, 58, 10.3945/ajcn.115.128819 · DOI
  164. Lajous, 2016, Flavonoid Intake and Incident Hypertension in Women, Am. J. Clin. Nutr., 103, 1091, 10.3945/ajcn.115.109249 · DOI
  165. Mastroiacovo, 2015, Cocoa Flavanol Consumption Improves Cognitive Function, Blood Pressure Control, and Metabolic Profile in Elderly Subjects: The Cocoa, Cognition, and Aging (CoCoA) Study-A Randomized Controlled Trial, Am. J. Clin. Nutr., 101, 538, 10.3945/ajcn.114.092189 · DOI · Paper page
  166. Ahuja, 2017, Significant Inverse Association of Equol-Producer Status with Coronary Artery Calcification but Not Dietary Isoflavones in Healthy Japanese Men, Br. J. Nutr., 117, 260, 10.1017/S000711451600458X · DOI
  167. Bertoia, 2016, Dietary Flavonoid Intake and Weight Maintenance: Three Prospective Cohorts of 124 086 US Men and Women Followed for up to 24 Years, BMJ, 352, i17, 10.1136/bmj.i17 · DOI · Paper page
  168. Huang, 2015, 5-Caffeoylquinic Acid Decreases Diet-Induced Obesity in Rats by Modulating PPARα and LXRα Transcription, J. Sci. Food Agric., 95, 1903, 10.1002/jsfa.6896 · DOI · Paper page
  169. Ong, 2013, Anti-Diabetic and Anti-Lipidemic Effects of Chlorogenic Acid Are Mediated by Ampk Activation, Biochem. Pharmacol., 85, 1341, 10.1016/j.bcp.2013.02.008 · DOI · Paper page
  170. Ma, 2015, Chlorogenic Acid Improves High Fat Diet-Induced Hepatic Steatosis and Insulin Resistance in Mice, Pharm. Res., 32, 1200, 10.1007/s11095-014-1526-9 · DOI · Paper page
  171. Jin, S., Chang, C., Zhang, L., Liu, Y., Huang, X., and Chen, Z. (2015). Chlorogenic Acid Improves Late Diabetes through Adiponectin Receptor Signaling Pathways in Db/Db Mice. PLoS ONE, 10. · DOI
  172. Wan, 2013, Chlorogenic Acid Exhibits Cholesterol Lowering and Fatty Liver Attenuating Properties by Up-Regulating the Gene Expression of PPAR-α in Hypercholesterolemic Rats Induced with a High-Cholesterol Diet, Phytother. Res., 27, 545, 10.1002/ptr.4751 · DOI · Paper page
  173. Bondonno, 2012, Acute Effects of Chlorogenic Acid on Nitric Oxide Status, Endothelial Function and Blood Pressure in Healthy Volunteers: A Randomised Trial, Free Radic. Biol. Med., 53, 9130, 10.1016/j.freeradbiomed.2012.08.402 · doi:10.1016/j.freeradbiomed.2012.08.402
  174. Amalraj, 2017, Biological Activities of Curcuminoids, Other Biomolecules from Turmeric and Their Derivatives—A Review, J. Tradit Complement. Med., 7, 205, 10.1016/j.jtcme.2016.05.005 · DOI · Paper page
  175. Gupta, 2013, Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials, AAPS J., 15, 195, 10.1208/s12248-012-9432-8 · DOI · Paper page
  176. Goel, 2008, Curcumin as “Curecumin”: From Kitchen to Clinic, Biochem. Pharmacol., 75, 787, 10.1016/j.bcp.2007.08.016 · DOI · Paper page
  177. Tomeh, M.A., Hadianamrei, R., and Zhao, X. (2019). A Review of Curcumin and Its Derivatives as Anticancer Agents. Int. J. Mol. Sci., 20. · DOI · Paper page
  178. Wu, L.Y., Chen, C.W., Chen, L.K., Chou, H.Y., Chang, C.L., and Juan, C.C. (2019). Curcumin Attenuates Adipogenesis by Inducing Preadipocyte Apoptosis and Inhibiting Adipocyte Differentiation. Nutrients, 11. · DOI
  179. Bressan, 2015, Potential Role of Bioavailable Curcumin in Weight Loss and Omental Adipose Tissue Decrease: Preliminary Data of a Randomized, Controlled Trial in Overweight People with Metabolic Syndrome. Preliminary Study, Eur. Rev. Med. Pharmacol. Sci., 19, 4195
  180. Panahi, 2015, Antioxidant and Anti-Inflammatory Effects of Curcuminoid-Piperine Combination in Subjects with Metabolic Syndrome: A Randomized Controlled Trial and an Updated Meta-Analysis, Clin. Nutr., 34, 1101, 10.1016/j.clnu.2014.12.019 · DOI · Paper page
  181. Taye, 2011, The Antihyperglycemic Effect of Curcumin in High Fat Diet Fed Rats. Role of TNF-α and Free Fatty Acids, Food Chem. Toxicol., 49, 1129, 10.1016/j.fct.2011.02.004 · DOI · Paper page
  182. Thota, R.N., Rosato, J.I., Dias, C.B., Burrows, T.L., Martins, R.N., and Garg, M.L. (2020). Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3Β and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer’s Disease. Nutrients, 12. · DOI · Paper page
  183. Bateni, 2021, The Effects of Nano-Curcumin Supplementation on Glycemic Control, Blood Pressure, Lipid Profile, and Insulin Resistance in Patients with the Metabolic Syndrome: A Randomized, Double-Blind Clinical Trial, Phytother. Res., 35, 3945, 10.1002/ptr.7109 · DOI
  184. Auger, 2018, Risperidone-Induced Metabolic Dysfunction Is Attenuated by Curcuma Longa Extract Administration in Mice, Metab. Brain Dis., 33, 63, 10.1007/s11011-017-0133-y · DOI
  185. Kassaian, 2019, Probiotic and Synbiotic Supplementation Could Improve Metabolic Syndrome in Prediabetic Adults: A Randomized Controlled Trial, Diabetes Metab. Syndr. Clin. Res. Rev., 13, 2991, 10.1016/j.dsx.2018.07.016 · DOI · Paper page
  186. Tenorio-Jiménez, C., Martínez-Ramírez, M.J., del Castillo-Codes, I., Arraiza-Irigoyen, C., Tercero-Lozano, M., Camacho, J., Chueca, N., García, F., Olza, J., and Plaza-Díaz, J. (2019). Lactobacillus Reuteri V3401 Reduces Inflammatory Biomarkers and Modifies the Gastrointestinal Microbiome in Adults with Metabolic Syndrome: The PROSIR Study. Nutrients, 11. · DOI
  187. Moles, L., and Otaegui, D. (2020). The Impact of Diet on Microbiota Evolution and Human Health. Is Diet. an Adequate Tool for Microbiota Modulation?. Nutrients, 12. · DOI
  188. Oriach, 2016, Food for Thought: The Role of Nutrition in the Microbiota-Gut-Brain Axis, Clin. Nutr. Exp., 6, 25, 10.1016/j.yclnex.2016.01.003 · DOI · Paper page
  189. Garaulet, 2014, Beneficial Effect of CLOCK Gene Polymorphism Rs1801260 in Combination with Low-Fat Diet on Insulin Metabolism in the Patients with Metabolic Syndrome, Chronobiol. Int., 31, 401, 10.3109/07420528.2013.864300 · DOI · Paper page
  190. Milagro, 2017, Guide for Current Nutrigenetic, Nutrigenomic, and Nutriepigenetic Approaches for Precision Nutrition Involving the Prevention and Management of Chronic Diseases Associated with Obesity, J. Nutrigenet. Nutri., 10, 43

Cited by

Metadata

Authors
Ambroselli, D., Masciulli, F., Romano, E., Catanzaro, G., Besharat, Z. M., Massari, M. C., Ferretti, E., Migliaccio, S., Izzo, L., Ritieni, A., Grosso, M., Formichi, C., Dotta, F., Frigerio, F., Barbiera, E., Giusti, A. M., Ingallina, C., & Mannina, L.
Venue
Nutrients
Publisher
MDPI AG
Published
2023-01-26
Volume
15
Issue
3
Pages
640
ISSN
2072-6643 (ISSN-L)
OpenAlex
W4318208160
Cited by
214
References
35
FWCI
49.29
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.